The field of neuromodulation, or the introduction of nerve stimulation into the central nervous system, peripheral nervous system, autonomic nervous system, or deep cell nuclei of the brain via an implantable device, has produced numerous start-ups and a decent amount of medtech funding over the past six years.
We used Informa's Strategic Transactions to review neuromodulation deal activity from 2009-2014. Several larger device companies have made investments in neuromodulation firms and retained an option to buy at a...